By comparing data from patients with CRC who received chemoradiotherapy (GSE15781 dataset), we found that STING-dependent type I IFN and TRAIL signatures were significantly increased in tissues obtained after chemoradiotherapy (CRT) compared with pre-CRT biopsies (Fig. S1A). This evidence concerns the gene STING1 and colorectal carcinoma.